Satellos Bioscience Inc. (MSLE) Operating income 2024–2025
Satellos Bioscience Inc. (MSLE) annual operating income history from SEC filings — each fiscal year as reported.
-$26.5MFY2025 · since FY2024: -$20.4M → -$26.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$26.5M | -29.7% |
| FY2024 | -$20.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MSLE financial trends
MSLE RevenueMSLE Net incomeMSLE Net marginMSLE Gross profitMSLE Gross marginMSLE Operating marginMSLE Operating cash flowMSLE Free cash flowMSLE Capital expendituresMSLE Return on equityMSLE Stock buybacksMSLE Dividends paidMSLE Total assetsMSLE Total liabilitiesMSLE Shareholders’ equityMSLE overview →